If you've started a GLP-1 medication for weight management, or you're considering one, most of the conversation tends to focus on the number on the scale. But weight loss isn't only about fat. Any method of losing a significant amount of weight, including with GLP-1 or GLP-1/GIP medications, can involve some loss of lean tissue, commonly called muscle mass, along with fat. Understanding why that happens, and what can help support lean mass along the way, is worth knowing before and during treatment.
This article is patient education, not medical advice. Only an independent licensed medical professional can evaluate your personal health history and help build a nutrition and activity plan that's appropriate for you.
Why weight loss with GLP-1 medications isn't only about fat
GLP-1 medications work by mimicking a natural gut hormone that helps regulate appetite and slows how quickly food moves through the stomach, which tends to reduce how much a person eats. Over time, that reduced calorie intake produces meaningful weight loss for many people. But when the body is in a calorie deficit, whether from a GLP-1 medication, a structured diet, or another method entirely, it doesn't draw only from fat stores. Some proportion of the tissue lost is typically lean mass, including skeletal muscle.
This isn't unique to GLP-1 medications. Weight loss from dietary changes alone, from bariatric surgery, and from pharmacologic treatment all share this general pattern to varying degrees. What differs between methods, and between individuals, is how much lean mass is affected and what can be done to influence that balance. That's the more useful question, and it's one researchers and clinicians have been paying closer attention to as GLP-1 treatment has become more widely used.
Why does this distinction matter in practice? Muscle isn't only about strength or appearance. It plays a role in daily function, in how the body uses energy, and, for older adults especially, in mobility and independence over time. That's part of why the conversation around GLP-1 treatment has expanded beyond total weight lost to include the composition of that weight loss, and why planning ahead, rather than reacting after the fact, tends to be the more useful approach.
What research says about lean mass during GLP-1 treatment
Clinical trial data on GLP-1 and GLP-1/GIP medications, the same class that includes FDA-approved products such as Wegovy® and Zepbound™, as well as compounded versions of semaglutide and tirzepatide, have measured body-composition changes in some study populations using imaging tools. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality, though they may be prescribed by an independent licensed physician when clinically appropriate. Across that broader body of research, some portion of total weight lost has generally included lean mass alongside fat mass, a pattern researchers have also observed with other substantial weight-loss methods.
Exactly how much lean mass is affected, and how meaningfully that matters for an individual, varies. Factors like age, baseline muscle mass, diet quality, and physical activity during treatment all appear to play a role. This remains an active area of clinical interest, and researchers continue to study how to help patients preserve more lean mass while still achieving meaningful fat loss.
It's also worth being clear about what this evidence does not show. It does not show that GLP-1 medications are uniquely harmful to muscle compared with other effective weight-loss approaches, and it does not mean that lean-mass loss is unavoidable or that treatment should be avoided because of it. Instead, it points to a practical takeaway: pairing GLP-1 treatment with habits that support lean mass is a reasonable, evidence-informed step, not an optional afterthought.
Some lean-mass change is expected, not a sign something is wrong
Losing some lean mass alongside fat is a normal part of most substantial weight loss, not a specific problem with GLP-1 medications. The goal isn't to prevent it entirely, but to support the habits, like adequate protein and resistance exercise, that research suggests can help influence that balance.
The role of protein intake
Adequate dietary protein is one of the most consistently discussed strategies for supporting lean mass during intentional weight loss. Protein provides the building blocks the body needs to maintain and repair muscle tissue, and getting enough of it becomes more relevant when overall calorie intake is reduced, since the body has less total energy and fewer amino acids available from food.
There's no single protein target that applies to everyone. How much protein is appropriate depends on body size, activity level, kidney function, and other individual health factors, which is why this is something to work out with a clinician or registered dietitian rather than a generic online recommendation. Spreading protein intake across meals, rather than concentrating it in one sitting, is a pattern often discussed as well, though individual needs still vary.
Because GLP-1 medications can reduce appetite significantly, some people find it harder to eat enough total food, including protein, especially early in treatment. Our guide to what to expect in your first month of GLP-1 treatment covers how appetite changes are typically managed during the early weeks.
Some people find it helpful to prioritize protein-rich foods earlier in a meal, before appetite fades, or to lean on foods that are easier to tolerate if nausea is present during dose titration. None of this replaces individualized guidance, but it illustrates why nutrition planning during GLP-1 treatment is often approached differently than nutrition planning without a medication that changes appetite this directly.
The role of resistance and strength training
Physical activity, including resistance or strength training, is commonly discussed as a complementary part of a GLP-1 treatment plan. The NIDDK describes physical activity as an important part of a comprehensive approach to weight management, alongside dietary changes and, when appropriate, medication. Resistance training specifically, such as weightlifting or bodyweight exercises, works muscle tissue in a way that can help support its maintenance during a period of calorie deficit.
This doesn't mean an intense or complicated program is required. For many people, a manageable routine that gradually builds strength, combined with adequate protein, is more sustainable than an aggressive plan that's hard to stick with. As with nutrition, the right amount and type of activity depends on a person's baseline fitness, other health conditions, and personal goals, which a clinician can help think through.
Consistency tends to matter more than intensity. A couple of sessions a week that work the major muscle groups, whether with weights, resistance bands, or bodyweight movements, is a reasonable starting point for many people, and it can be adjusted as fitness improves. People who are new to structured exercise, or who have joint issues or other health conditions, may benefit from starting with guidance from a physical therapist or trainer familiar with their history.
Supporting lean mass during treatment connects closely to what happens after a course of GLP-1 treatment ends, too. Our article on maintaining weight after GLP-1 treatment goes further into how nutrition and activity continue to matter beyond active treatment.
Working with a clinician on a muscle-preserving plan
Because factors like age, starting muscle mass, kidney function, and other health conditions all influence what a reasonable protein and activity plan looks like, this isn't something to figure out alone. A licensed clinician can review your health history and current habits as part of your GLP-1 treatment plan, and help set expectations that fit your situation specifically, rather than a generic template.
This kind of individualized guidance is part of the broader monitoring that responsible GLP-1 treatment involves, alongside tracking for the more commonly discussed side effects of GLP-1 medications. Whether you're taking an FDA-approved brand or, when clinically appropriate, a compounded formulation, as explained in our overview of how compounded GLP-1s work, the same general principles around nutrition and activity apply. You can browse more explainers in our Weight Management category.
Follow-up visits during GLP-1 treatment are a natural point to revisit how nutrition and activity are going, not just to check in on dosing or side effects. Bringing questions about protein intake, exercise, or unexpected fatigue to those visits gives a clinician the information needed to adjust the plan as treatment progresses, rather than waiting until a concern becomes significant.
The bottom line
Weight loss achieved with GLP-1 medications typically involves a mix of fat and lean tissue, similar to what's seen with other significant weight-loss methods, rather than fat loss alone. Adequate protein intake and resistance or strength training are strategies commonly discussed for supporting lean mass during treatment, though individual needs vary widely based on age, starting muscle mass, and overall health. A licensed clinician can help build a nutrition and activity plan tailored to your circumstances as part of ongoing GLP-1 treatment.
Important Safety Information
Indication. GLP-1 receptor agonists are medications used, when clinically appropriate, to support blood sugar management or chronic weight management alongside a reduced-calorie diet and increased physical activity. FDA-approved brands include Ozempic® and Wegovy® (semaglutide) and Mounjaro® and Zepbound™ (tirzepatide). Compounded GLP-1 medications are not FDA-approved.
Common side effects. The most commonly reported side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. These are often mild and tend to ease over time, especially as the dose is increased gradually.
Warnings. These medications carry a boxed warning regarding thyroid C-cell tumors seen in rodent studies. Do not use if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about any history of pancreatitis, gallbladder disease, or kidney problems, or if you are pregnant, planning to become pregnant, or breastfeeding. Seek care for severe abdominal pain or signs of a serious allergic reaction.
Talk to your doctor. This information is educational and is not a substitute for medical advice. Only a licensed medical professional can determine whether a treatment is right for you. Talk to your doctor about the benefits and risks, and report any side effects.
Frequently asked questions
Does GLP-1 treatment cause muscle loss?
Weight loss achieved with GLP-1 medications, like weight loss from any significant method, typically includes a combination of fat and lean (muscle) tissue, not fat exclusively. The exact proportion varies between individuals and depends on factors such as diet, activity level, and age, which is one reason clinicians often recommend pairing GLP-1 treatment with adequate protein intake and resistance exercise.
How much of the weight lost with GLP-1 medications is muscle versus fat?
There isn't one fixed ratio that applies to everyone. Research on GLP-1 and GLP-1/GIP medications has found that some of the total weight lost can be lean mass, a pattern also seen with other significant weight-loss methods, but individual results vary considerably based on nutrition, physical activity, and other personal factors.
Can eating more protein help preserve muscle during GLP-1 treatment?
Adequate dietary protein is commonly discussed as part of supporting lean mass during intentional weight loss, including while using GLP-1 medications. A clinician or registered dietitian can help determine an appropriate protein target for your individual needs, since requirements vary by body size, activity level, and health history.
Is strength training necessary while taking a GLP-1 medication?
Strength training isn't mandatory, but it's often recommended alongside GLP-1 treatment. The NIDDK describes physical activity, including resistance exercise, as an important part of a comprehensive weight-management plan. Combining resistance training with adequate protein intake is a common approach clinicians discuss for supporting lean mass.
Are older adults more likely to lose muscle during GLP-1 treatment?
Age can be a relevant factor. Older adults may start with less muscle mass and can be more susceptible to further lean-mass loss during any significant weight loss, which is why clinicians may pay closer attention to nutrition and activity recommendations for older patients using GLP-1 medications.
Should I talk to my clinician about preserving muscle before starting GLP-1 treatment?
Yes. A licensed clinician can review your health history, current activity level, and nutrition, and help build a plan that supports lean mass alongside your weight-management goals. This individualized guidance is part of the ongoing monitoring that responsible GLP-1 treatment involves.
